Cargando…
Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial
Drug-eluting stents (DES) are the recommended stents for primary percutaneous coronary intervention (PCI). This study aimed to determine why interventional cardiologists used non-DES and how it influenced patient prognoses. The efficacy and safety outcomes of the different stents were also compared...
Autores principales: | Hlinomaz, Ota, Motovska, Zuzana, Knot, Jiri, Miklik, Roman, Sabbah, Mahmoud, Hromadka, Milan, Varvarovsky, Ivo, Dusek, Jaroslav, Svoboda, Michal, Tousek, Frantisek, Majtan, Bohumil, Simek, Stanislav, Branny, Marian, Jarkovský, Jiří |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584734/ https://www.ncbi.nlm.nih.gov/pubmed/34768623 http://dx.doi.org/10.3390/jcm10215103 |
Ejemplares similares
-
The Effect of Diabetes on Prognosis Following Myocardial Infarction Treated with Primary Angioplasty and Potent Antiplatelet Therapy
por: Simek, Stanislav, et al.
Publicado: (2020) -
MiR-126-3p and MiR-223-3p as Biomarkers for Prediction of Thrombotic Risk in Patients with Acute Myocardial Infarction and Primary Angioplasty
por: Hromadka, Milan, et al.
Publicado: (2021) -
Trends in outcomes of women with myocardial infarction undergoing primary angioplasty—Analysis of randomized trials
por: Motovska, Zuzana, et al.
Publicado: (2023) -
Impact of the COVID-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction
por: Motovska, Zuzana, et al.
Publicado: (2023) -
Prognostic Value of MicroRNAs in Patients after Myocardial Infarction: A Substudy of PRAGUE-18
por: Hromádka, M., et al.
Publicado: (2019)